Breast Cancer Awareness: How Early Diagnosis Changes the Course of Cancer Treatment

Breast Cancer Awareness Day serves as an important reminder that early detection can make a significant difference – time matters. Early detection of breast cancer usually makes the treatment simpler and even makes it possible for patients to survive this disease. However, the majority of patients ignore the screening tests since they have no symptoms of the disease and think they cannot develop it because it manifests itself in lumps.

Understanding what early diagnosis really means, how genetic testing adds to the picture, and why it changes so much about treatment, can help people make more informed choices about their own health.

Breast cancer can begin long before a lump or a visible change is noticeable. In its earliest stage, cancer cells may be too small to feel by touch. This is exactly why mammograms exist. They can pick up changes years before symptoms would ever appear on their own.^[2]

There are some early signs that are still worth noting even though they do not in themselves prove the existence of cancer:^[1]

• Unexplained pain in the breasts or armpit area

• Changes in skin texture, like puckering

• Discharge, inversion, or any abnormal change in the nipple

• Swelling in part of the breast, even without a lump

• Anything that simply feels different from what is normal for you

Any of these is a reason to speak with a doctor, not a reason to assume the worst.

No single habit can guarantee prevention, but many things done on a regular basis have been associated with decreased risk. It is often what you do consistently that counts.

• Maintain a healthy BMI, especially after menopause.

• Breastfeed for a few months, where possible.

• Discuss family history with a doctor to understand personal risk.

Age, genetics, and hormonal history also play a role, which is exactly what screening is designed to account for.

Screening isn't one-size-fits-all. Age, family history, genetic risk, and existing health conditions all shape how early, and how often, a person should be screened. Someone with a strong family history may need to start years before someone with no known risk factors.

This is why the “right age” to start screening looks different for everyone, and why a personal conversation with a doctor matters more than a generic checklist.

Most breast cancers are not inherited, but a smaller share are linked to gene changes passed down in families. The best known are changes in the BRCA1 and BRCA2 genes, which raise the risk of breast and ovarian cancer.^[3]

BRCA1/BRCA2 germline testing checks for these inherited changes. “Germline” means the change has been present in the body's cells since birth. The test is usually done on a blood or saliva sample, and it is best done after genetic counselling, where a specialist explains what the result can and cannot tell you.

A doctor may suggest this test when a family history includes:

• Breast cancer diagnosed at a young age

• Breast and ovarian cancer in the same family

• More than one close relative with breast cancer

• Breast cancer in a male relative

• A BRCA change already found in a relative

A positive result does not mean a person has cancer. It means the risk is higher, and it can lead to earlier or more frequent screening, such as MRI, and a discussion about preventive options.

It is a screening test but not a definitive diagnosis. This is what happens afterwards:

1. The radiologist examines the pictures for any anomalies.

2. If the results are clear, then regular screenings will continue as usual.

3. If the results are unclear, further imaging such as an ultrasound or another mammogram may be suggested.

4. If an anomaly is detected: biopsy may be performed for further analysis of the suspicious tissues.

5. Biopsy results reveal whether the cells are cancerous and what kind of cancer it is.

False-positive results are common; many are caused by normal breast tissues, cysts or benign growths.

When breast cancer is detected early, treatment options are often broader and less intensive. A tumour caught before it spreads may need only localised treatment, while advanced cases often need a combination of approaches.

• Smaller surgeries, sometimes breast-conserving rather than full removal.

• Lower likelihood of needing extensive chemotherapy

• Reduced need to treat cancer that has spread to other organs

• Typically better long-term outcomes, though every case is different

Early diagnosis doesn't just save time. It often preserves more options for the patient.

Cancer stages are terms to indicate how far the disease has progressed, from confined within the breast in its early stage to spread beyond it in advanced stages. Staging guides nearly every treatment decision, from the type of surgery to whether chemotherapy or radiation is needed.

• Early-stage cancers are treated with surgery or with limited additional therapy.

• Later-stage cancers often need a combination of surgery, chemotherapy, radiation, and sometimes targeted therapy.

This is one reason doctors don't treat “breast cancer” as a single condition. They treat its stage.

Two people with a breast cancer diagnosis can end up with completely different treatment plans. That's because breast cancer isn't a single disease. It has multiple subtypes, each responding differently to therapy.

• Cancer subtype, such as hormone receptor status

• Tumour size and location

• Whether nearby lymph nodes are involved

• The patient's age, overall health, and personal preferences

This is why what worked for one person isn't always the right benchmark for someone else's treatment journey.

BRCA1 and BRCA2 are not the only genes linked to breast cancer. Next-generation sequencing, or NGS, is a technology that reads many genes in a single test. An NGS-based breast cancer panel looks at a set of genes known to be linked to the disease, which gives a wider and more detailed picture than testing one or two genes.

These panels can be used in two ways:

• Germline testing looks for inherited gene changes. It helps assess hereditary risk, guide screening and inform family members.

• Somatic testing studies the tumour itself for changes that developed during a person's lifetime. It helps describe the cancer at a molecular level and shows whether certain targeted treatments may work.

Together, these results can support risk assessment, diagnosis and treatment decisions, and help shape a more personalised plan of care. Genetic and molecular tests work alongside mammograms, biopsy and a doctor's judgement, not in place of them.

Breast health isn't a once-a-year task. It's an ongoing habit, and simple, consistent steps make the biggest difference over time.

1. Get familiar with how your breasts normally look and feel

2. Schedule screenings based on your age and risk profile

3. Don't delay a doctor's visit for an unusual change

4. Maintain a healthy lifestyle: balanced diet, regular activity.

5. Talk to family members about hereditary risk factors

Awareness isn't about fear. It's about staying informed and proactive.

Breast cancer outcomes are shaped as much by timing as by treatment itself. Early diagnosis often means simpler treatment, more options, and better long-term outlooks. This Breast Cancer Awareness Month, the most powerful action isn't a grand gesture. It's a scheduled screening, a doctor's visit for a concerning change, or simply understanding your own risk, including whether genetic testing is right for you.

Small steps, taken early, can make all the difference.